Menta Capital’s Edwards Lifesciences EW Stock Holding History

Menta Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,308	Closed	-$373K	–	534
2018 Q4	$373K	Buy	+7,308	New	+$370K	0.14%	240
2017 Q2	–	Sell	-37,080	Closed	-$1.16M	–	799
2017 Q1	$1.16M	Buy	+37,080	New	+$1.16M	0.11%	302
2016 Q2	–	Sell	-15,180	Closed	-$446K	–	889
2016 Q1	$446K	Sell	15,180 -70,200	-82%	-$1.94M	0.06%	541
2015 Q4	$2.25M	Buy	+85,380	New	+$2.22M	0.29%	69
2015 Q2	–	Sell	-85,800	Closed	-$2.04M	–	692
2015 Q1	$2.04M	Sell	85,800 -28,440	-25%	-$638K	0.26%	128
2014 Q4	$2.42M	Sell	114,240 -28,560	-20%	-$574K	0.34%	81
2014 Q3	$2.43M	Buy	142,800 +98,400	+222%	+$1.55M	0.4%	66
2014 Q2	$635K	Buy	+44,400	New	+$602K	0.12%	238

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Menta Capital's EW Position: Q1 2019 in Review

Menta Capital sold out of Edwards Lifesciences (EW) in Q1 2019, closing a stake of 7,308 shares — an estimated $373K sold.

Menta Capital first reported a position in EW in Q2 2014 and held it in 8 quarters. The position peaked at $2.43M in Q3 2014. 923 funds tracked by Wall St. Rank hold EW as of Q1 2019.

Menta Capital reported no remaining Edwards Lifesciences position as of Q1 2019 after selling out during the quarter.
Menta Capital sold 7,308 Edwards Lifesciences shares in Q1 2019, an estimated $373K.
Menta Capital first reported a position in Edwards Lifesciences in Q2 2014 and held it in 8 quarters.
Menta Capital's Edwards Lifesciences position peaked at $2.43M in Q3 2014.
923 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on Menta Capital's 13F filing for Q1 2019, filed 1 May 2019.